Follow US:
The Regents of the University of California have given final approval for the construction of the School of Medicine’s new Education Building II at UC Riverside. The vote, which approved the final design, the full budget, and the California Environmental Quality Act, or CEQA, findings, took place during the Regents’...
UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
C OVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside...
UC Riverside-led study examined the effects of the medication risperidone on brain metabolism in stuttering
UC Riverside-led mouse study stresses MS treatment should be started early
UC Riverside epidemiologist answers this and other questions in Q&A
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines
A UC Riverside-led study, funded by Merck, is set to find out
UC Riverside study examines molecular pathways that may instigate seizures in some multiple sclerosis patients
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
Host campus UC Riverside will be joined by UC Davis and UC Merced
Meeting virtually with people outside your household is safest, says UC Riverside epidemiologist
Neural crest study results could boost stem cell therapies
The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...
UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
Policy has limited impact on vaccine uptake because of individual decision making, study finds
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
Dr. Paul Offit, an international expert on vaccines, will give the 2020 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
